HeyJaredPancChat Podcast with Alisyn Camerota
The PancChat Podcast is a collaborative effort from Let’s Win Pancreatic Cancer and the Pancreatic Cancer Action Network (PanCAN), inspired by the long-running PancChat Twitter/X chat.Hosted by award-winning journalist Alisyn Camerota, each episode features conversations with…
- Indexed episodes, last 90 days
- 5
- Latest publication
- Sep 8, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 14, 2026
Latest episodes
Rasonque™: A New Drug for Pancreatic Cancer (opens the original)
Read excerpt
The U.S. Food & Drug Administration (FDA) just approved a treatment that doubled survival time for patients with metastatic pancreatic cancer — what does this landmark approval mean for you or a loved one? To get the latest information, host Alisyn Camerota is joined by Dr. Brian Wolpin, a medical oncologist at Dana-Farber Cancer Institute and professor of medicine at Harvard Medical School. Dr. Wolpin breaks down what the FDA's approval of Rasonque™ (daraxonrasib) means for patients, how the dr
Managing Diabetes During Treatment (opens the original)
Read excerpt
Diabetes and pancreatic cancer often go hand in hand. Between 30 to 50% of patients have diabetes or prediabetes at diagnosis, and another 40% develop it during treatment. To get the latest information, host Alisyn Camerota is joined by endocrinologist and Director of the Duke Onco-Endocrinology Program at the Duke Center for Cancer Immunotherapy, Dr. Afreen Shariff, an Associate Director for the Cancer Therapy Toxicity Program and a member of the faculty in the Division of Endocrinology, Diabet
The Link Between Diabetes and Pancreatic Cancer (opens the original)
Read excerpt
Almost one in four people diagnosed with pancreatic cancer are also diagnosed with diabetes. In this episode of PancChat, host Alisyn Camerota talks with Dr. Suresh Chari, professor of medicine at MD Anderson Cancer Center and principal investigator for the PanCAN Early Detection Initiative, about the complex relationship between diabetes and pancreatic cancer. Dr. Chari explains why new-onset diabetes can be an early warning sign for pancreatic cancer, why a sudden rise in blood sugar alongside
Emerging Trials in Pancreatic Cancer (opens the original)
Read excerpt
With one new drug against the KRAS mutation on the path to FDA approval, what is the status of other KRAS drugs, as well as different types of treatment? To get the latest information, host Alisyn Camerota is joined once again by Dr. Allyson Ocean, medical oncologist and director of the Pancreatic Cancer Research Program at Weill Cornell Medicine, and a co-founder of Let's Win, along with Dr. Anna Berkenblit, Chief Scientific and Medical Officer for PanCAN, who brings more than two decades of ex
Advancements This Year (opens the original)
Read excerpt
New pancreatic cancer treatments have not been approved in many years, but the first half of 2026 has seen some significant treatment advances. In this episode, host Alisyn Camerota talks with Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer, and Dr. Allyson Ocean, director of the pancreatic cancer research program at Weill Cornell Medicine and co-founder of Let's Win Pancreatic Cancer, about what's changing and what it means for patients. Dr. Berkenblit and Dr. Ocean discuss t
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.